Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Peyer Insider Profile
4 Followers
James Peyer, Director, Ten Percent Owner at Sensei Biotherapeutics, holds 3.65M shares in Sensei Biotherapeutics (Ticker: SNSE).
James Peyer Sensei Biotherapeutics (SNSE)Director, Ten Percent Owner
Sensei Biotherapeutics (SNSE)
Director, Ten Percent Owner
Ranked #96,071 out of 97,997 Corporate Insiders
Profitable Transactions
0 out of 44 Profitable Transactions
Average Return
-74.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director, Ten Percent Owner
Roles that James Peyer holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 02, 2022 - Mar 02, 2023
Return:-49.40%
The most profitable trade made by James Peyer
James Peyer's Trading History
List of latest transactions for each holding click on a transaction to see James Peyer's performance on stock
You May Also Like
James Peyer insider profile FAQ
What is the percentage of profitable transactions made by James Peyer?
The percentage of profitable transactions made by James Peyer is 0%.
What is the average return per transaction made by James Peyer?
The average return per transaction made by James Peyer is -74.10%.
What stocks does James Peyer hold?
James Peyer holds: SNSE stocks.
What was James Peyer’s latest transaction?
James Peyer latest transaction was an Uninformative Sell of $2.00M.
What was James Peyer's most profitable transaction?
James Peyer’s most profitable transaction was an Informative Buy of SNSE stock on March 2, 2022. The return on the trade was -49.40%.
What is James Peyer's role in Sensei Biotherapeutics?
James Peyer's role in Sensei Biotherapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.